CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Labiotech.eu
Original article

Novartis’ strategy in 2026: rebuilding the pipeline after Entresto 

EntrestoNeutral
AI Analysis

Summary

Novartis is focusing on rebuilding its pipeline in 2026 following the spinoff of its biosimilars and generics business Sandoz, with plans for intensive dealmaking activities.

Importance:3/10
Sentiment:
0.00
pipeline strategyspinoffdealmakingbusiness restructuring
Related Companies

Read the original article

Published by Labiotech.eu on July 3, 2026 1:00 PM

Read Original